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One key aspect of the virulence of Staphylococcus aureus lies in its ability to target the
host cell membrane with a large number of membrane-damaging toxins and peptides. In
this review, we describe the hemolysins, the bi-component leukocidins (which include the
Panton Valentine leukocidin, LukAB/GH, and LukED), and the cytolytic peptides (phenol
soluble modulins). While at ﬁrst glance, all of these factors might appear redundant, it is
now clear that some of these factors play speciﬁc roles in certain S. aureus life stages and
diseases or target speciﬁc cell types or species. In this review, we present an update of the
literature on toxin receptors and their cell type and species speciﬁcities. Furthermore, we
review epidemiological studies and animal models illustrating the role of these membrane-
damaging factors in various diseases. Finally, we emphasize the interplay of these factors
with the host immune system and highlight all their non-lytic functions.
Keywords: Staphylococcus aureus, hemolysin, leukocidin, Panton Valentine leukocidin, PSM, inflammasome,
pore-forming toxin, neutrophil
INTRODUCTION
Staphylococcus aureus is both a commensal bacterium found in
about 30% of the healthy population and is one of the most
virulent bacterial pathogens. The ability of this bacterium to
cause diseases is associated with a large number of virulence fac-
tors allowing colonization and persistence, dissemination within
the host, and evasion of the immune system. The set of vir-
ulence factors required to cause disease is likely to be highly
dependent on the site of infection [e.g., skin and soft tissues
infections (SSTI) versus infective endocarditis]. Particularly, S.
aureus secretes numerous exotoxins, including a groupof polypep-
tides capable of damaging the host cell plasma membrane. These
polypeptides include pore-forming toxins [PFT: α-hemolysin and
the bi-component leukocidins γ-hemolysin, the Panton Valentine
leukocidin (PVL), LukED, and LukGH/AB], β-hemolysin (a neu-
tral sphingomyelinase), and the phenol soluble modulins (PSMs,
a family of small amphipathic peptides). While leukotoxic and
hemolytic activities (the ability to lyse leukocytes and red blood
cells, respectively) in S. aureus supernatant was described more
than a century ago (Julianelle, 1922; Panton and Valentine, 1932),
our understanding of the speciﬁc and physiological roles of the
various toxins remains far from complete. The receptor for α-
hemolysin, one of the most studied virulence factors since its
discovery in the beginning of the past century, has only been
identiﬁed recently, leading to novel important insights concern-
ing the function of this toxin (Wilke and Bubeck Wardenburg,
2010; Inoshima et al., 2011). Furthermore, several highly expressed
membrane-damaging (poly)peptides have been discovered in the
past 5 years (Queck et al., 2009;Ventura et al., 2010; Dumont et al.,
2011) highlighting both the gaps in knowledge and the exten-
sive research efforts aimed at uncovering the function of these
membrane-damaging toxins. The goal of this review is to give an
update on the different membrane-damaging toxins and their role
in S. aureus-mediated diseases. Themolecularmechanisms of pore
formation, which have been reviewed before (Kaneko and Kamio,
2004; Verdon et al., 2009), are not detailed here. Instead, we focus
on understanding the interactions between these virulence fac-
tors and various host cells from different species and review their
roles in S. aureus-mediated diseases. Furthermore, we describe the
interplay between the innate immune system, which has evolved
to sense membrane damage, and these virulence factors, several of
which speciﬁcally target innate immune cells. Finally, we present
the moonlighting activities of these toxins and discuss how these
activities could be more relevant than the toxins’ lytic activity in
colonization and diseases.
OVERVIEW OF THE DIFFERENT CLASSES OF
MEMBRANE-DAMAGING (POLY)PEPTIDES
α-HEMOLYSIN
α-Hemolysin is the most characterized virulence factor of S.
aureus. Upon binding to the cell surface, α-hemolysin monomers
assemble into a homoheptamer, forming a prepore. The prepore
subsequently transitions to amatureβ-barrel transmembranepore
(Bhakdi and Tranum-Jensen, 1991), thereby leading to the forma-
tion of a 14-Å diameter aqueous channel (Song et al., 1996). This
pore allows the transport of molecules smaller than 2 kD (Menest-
rina, 1986), such as K+ and Ca2+ ions, leading to necrotic death
of the target cell.
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γ-HEMOLYSIN AND BI-COMPONENT LEUKOCIDINS
Staphylococcus aureus possesses several other PFTs in addition toα-
hemolysin. In contrast to α-hemolysin, the formation of a mature
pore by these other PFTs involves two polypeptides that have been
named S (slow) and F (fast) based on their electrophoretic mobil-
ity. The different S. aureus bi-component PFTs share signiﬁcant
homology (see Supplemental Figure S3 in Dumont et al., 2011).
The PFTs include (i) γ-hemolysin corresponding to two combi-
nations of a S component (HlgA or HlgC) with a F component
(HlgB); (ii) the PVL (Panton andValentine, 1932), made of LukS-
PV and LukF-PV; (iii) LukED (Gravet et al., 1998; Morinaga et al.,
2003); (iv) LukGH (Ventura et al., 2010), also known as LukAB
(Dumont et al., 2011). The structure of these bi-component tox-
ins (Olson et al., 1999; Pedelacq et al., 1999; Guillet et al., 2004)
and their mechanism of pore formation have been mostly studied
using γ-hemolysin and PVL, but are thought to be similar for all
of the toxins. Each water-soluble component binds sequentially
to the cell surface as a monomer before oligomerizing into a pre-
pore formed by four S components alternatively arranged with
four F components. The mature hetero-octamer forms a trans-
membrane β-barrel pore across the plasma membrane, leading to
host cell lysis. The bi-component toxins are largely considered to
be secreted proteins. LukGH/AB was identiﬁed both as a secreted
protein in the extracellular medium and as one of the predomi-
nant surface protein of S. aureus at the late exponential phase of
growth (Ventura et al., 2010). Surface association of this leuko-
toxin might be involved in targeting immune cells when they are
in direct contact with the bacterium, such as during phagocytosis.
β-HEMOLYSIN
In contrast to the PFTs, the β-hemolysin does not formpores in the
plasma cell membrane but instead is a neutral sphingomyelinase
hydrolysing sphingomyelin, which is a plasma membrane lipid. β-
hemolysin’s enzymatic activity is required for its hemolytic activity
(Huseby et al., 2007; Ira and Johnston, 2008). β-hemolysin lysis of
red blood cells is only observed after the cells are switched to low
temperature, suggesting that the lytic activity of β-hemolysin is not
as efﬁcient as that of other hemolysins, at least toward erythrocytes.
β-hemolysin digests sphingomyelin into ceramide and phospho-
rylcholine (Doery et al., 1963). Themechanism leading to cytotox-
icity is still poorly understood. Sphingomyelin is enriched in lipid-
ordered membrane microdomains with high content in choles-
terol. Sphingomyelinase treatment of synthetic lipid bilayers leads
to aggregation of cholesterol-rich microdomains (Ira and John-
ston, 2008), suggesting that cell death may result from the modi-
ﬁcation of host cell plasma membrane ﬂuidity and destabilization
of the bilayer structure. Alternatively, cell death might result from
the formation of large ceramide-rich signaling platforms.
δ-HEMOLYSIN AND PSMs
This class of membrane-damaging peptides was identiﬁed over
60 years ago with the puriﬁcation of δ-hemolysin (Wiseman,
1975). δ-hemolysin is a small amphipathic (one hydrophobic and
one hydrophilic side) peptide (26 AA) with an α-helix struc-
ture. Three different mechanisms (reviewed in Verdon et al.,
2009) have been proposed to explain its hemolytic activity. Brieﬂy,
δ-hemolysin could (i) bind to the cell surface and aggregate to form
transmembrane pores; (ii) bind to the cell surface and affect the
membrane curvature, thereby destabilizing the plasmamembrane;
or (iii) at high concentration, act as a detergent to solubilize the
membrane. Recently, this family of small cytotoxic amphipathic
peptides has grown with the identiﬁcation of new peptides termed
PSM, ﬁrst in S. epidermidis (Mehlin et al., 1999) and subsequently
in S. aureus (Wang et al., 2007; Queck et al., 2009). Two families
of PSMs have been described based on their length (Wang et al.,
2007). PSMα, which include δ-hemolysin, PSMα1–4, and PSM-
mec (Queck et al., 2009), are 20–26 aminoacids long. In contrast,
PSMβ1 and PSMβ2 are 44 aminoacids long.
RECEPTORS, CELL, AND SPECIES SPECIFICITIES
Comparison of toxin activity between different studies conducted
using different cell types can be misleading, due to potential dif-
ferences in speciﬁc activities or to the presence of contaminants
linked to both the source of toxin (produced in S. aureus or in E.
coli) and the nature of the puriﬁcation process (see Craven et al.,
2009). Keeping this possibility in mind, we review the data from
the literature regarding toxin activity toward various cell types
below and in Table 1.
α-HEMOLYSIN
α-hemolysin displays species- and cell type speciﬁcity. While rab-
bit erythrocytes are highly sensitive toα-hemolysin-mediated lysis,
human erythrocytes are much less sensitive. Furthermore, while
human lymphocytes and monocytes are α-hemolysin-susceptible
cells (maximum lysis at 100 ng/ml), granulocytes are highly resis-
tant to α-hemolysin lysis (no lysis at 10μg/ml; Bhakdi et al., 1989;
Valeva et al., 1997; Lofﬂer et al., 2010). Similarly, lysis of human
lung epithelial cells (A549) is only observed at high α-hemolysin
concentrations (1μM id 30μg/ml; Rose et al., 2002; Wilke and
Bubeck Wardenburg, 2010). The cell type and species speciﬁcities
suggest the presence of a speciﬁc high afﬁnity receptor (Bhakdi and
Tranum-Jensen, 1991). Crystal structure of α-hemolysin bound
to phosphocholine (Galdiero and Gouaux, 2004) validated early
studies showing a requirement for phosphatidylcholine in gen-
erating α-hemolysin lytic activity against liposomes (Watanabe
et al., 1987). However, the presence of phosphatidylcholine as
a sole receptor cannot explain the low number of high afﬁnity
and saturable binding sites observed in rabbit erythrocytes. Val-
eva et al. (2006) showed that clustering of phosphocholine heads
into lipid rafts (microdomains) could create high afﬁnity bind-
ing sites. In agreement with this study, cholesterol depletion or
sphingomyelinase treatment, which affect lipid rafts decreases the
clustering of phosphatidylcholine lipids and abolishes the high
afﬁnity binding of α-hemolysin to rabbit erythrocytes. Recently,
a biochemical approach led to the identiﬁcation of A Disintegrin
and Metalloproteinase Domain-containing protein 10 (ADAM10)
as a α-hemolysin-interacting protein (Wilke and Bubeck Warden-
burg, 2010). α-Hemolysin binding to different cell types correlates
withADAM10expression. Furthermore,knock-downofADAM10
gene expression in A549 cells decreases both α-hemolysin bind-
ing and lytic activity. ADAM10 is highly expressed in A549
cells and rabbit erythrocytes but not on human erythrocytes.
To the best of our knowledge, the abundance of ADAM10 on
human granulocytes has not been investigated. The resistance of
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Table 1 | Species and cell type specificities of the various hemolysins, bi-component leukocidins, and PSMs.
Toxin/peptide Target cell (% lysis) Dose Reference
α-Hemolysin Human lymphocyte (80%) 100 ng/ml Valeva et al. (1997)
Jurkat cells and peripheral blood monocytes
(0%: resistant)
100 ng/ml up to 20μg/ml Bantel et al. (2001), Bhakdi et al. (1989)
Human granulocytes/neutrophils (0%:
resistant)
10μg/ml up to 20μg/ml Valeva et al. (1997), Lofﬂer et al. (2010), Bhakdi et al. (1989)
Human monocytes (90%) 80 ng/ml Bhakdi et al. (1989), Bantel et al. (2001)
A549 (40%) 375 nM (10μg/ml) Wilke and BubeckWardenburg (2010)
PVL Murine alveolar macrophages1 (280 nM) 10μg/ml Ziebandt et al. (2010)
Human macrophages (90%) 100 ng/ml Perret et al. (in press)
Human neutrophils (90%) 80 ng/ml Lofﬂer et al. (2010)
Murine neutrophils (20%) 40μg/ml Lofﬂer et al. (2010)
Rabbit neutrophils (90%) 60 ng/ml Lofﬂer et al. (2010)
LukAB/GH Human polymorphonuclear cells (60%) 2.5μg/ml Dumont et al. (2011)
LukED Murine peritoneal exudate cells (60%)2 2.5μg/ml Alonzo et al. (2012)
β-Hemolysin Sheep erythrocyte (50%)3 500 ng/ml Tajima et al. (2009)
HUVEC (resistant)4 1μg/ml Tajima et al. (2009)
Human ﬁbroblast (resistant) 1μg/ml (5μg/ml) Walev et al. (1996)
T lymphocyte (resistant) 1μg/ml (5μg/ml) Walev et al. (1996)
Granulocyte (resistant) 1μg/ml (5μg/ml) Walev et al. (1996)
Monocyte (50%) 0.001μg/ml (5 ng/ml) Walev et al. (1996)
Lymphocyte (NA)5 10μg/ml Huseby et al. (2007)
δ-Hemolysin HeLa 0.5 Hemolytic units/ml Thelestam et al. (1973)
Human neutrophils (5%) 10μg/ml Wang et al. (2007)
PSMα1 Human neutrophils (7.5%) 10μg/ml Wang et al. (2007)
PSMα2 Human neutrophils (10%) 10μg/ml Wang et al. (2007)
PSMα3 Human neutrophils (60%) 10μg/ml Wang et al. (2007)
PSM-mec Human neutrophils (12%) 50μg/ml Queck et al. (2009)
PSMβ1 Human blood (weak) 1μg/ml Cheung et al. (2011)
1Death monitored at 16 h post-intoxication.
2PEC were isolated from mice injected with S. aureus Newman strain 16 h before and intoxicated ex vivo with recombinant LukED.
3Hot–cold hemolysis.
4Human umbilical vein endothelial cells.
5Inhibition of proliferation.
human granulocytes to α-hemolysin does not seem to be due
to differences in α-hemolysin binding afﬁnity but rather to the
absence of insertion of the heptamer into the plasma membrane
(Valeva et al., 1997). While this granulocyte resistance has been
speculated to be associated with a speciﬁc response-inhibiting
membrane insertion of pore-forming toxins (Valeva et al., 1997),
the resistance might instead be linked to the absence of a co-
receptor. Indeed, scanning α-hemolysin sequence for eukaryotic
domains revealed a nine aminoacid motif resembling a caveolin-
1-binding domain (Pany et al., 2004). Recombinant caveolin-1
added exogenously inhibits α-hemolysin-mediated red blood cell
lysis, and α-hemolysin with a mutated caveolin-1 recognition site
is inactive, due to impaired heptamerization on the cell surface
(Pany et al., 2004). While ADAM10 could be involved in the ﬁrst
binding event, caveolin-1 might trigger a conformational change
allowing α-hemolysin insertion into membrane. The relevance
of caveolin-1-binding still needs to be thoroughly investigated,
but caveolin-1 appears to be highly expressed in the lung and
in epithelial cells (www.biogps.org). The expression patterns of
caveolin-1 andADAM10might thus explain the cell and the species
speciﬁcity observed for α-hemolysin. Furthermore, caveolae are
caveolin-1, cholesterol and sphingomyelin-rich microdomains at
the plasma membrane (Lajoie and Nabi, 2007). α-Hemolysin
treatment relocalizes ADAM10 to caveolin-1 positive domains
(Wilke and Bubeck Wardenburg, 2010). The connection between
phosphatidylcholine clusters, lipid rafts, caveolin-1, and ADAM10
remains unclear. Sequential binding to those different receptors
might be important to coordinate conformational changes and
α-hemolysin oligomerization to trigger cell-speciﬁc lysis or local-
ized ADAM10 activation in E-cadherin-containing caveolae (see
below).
γ-HEMOLYSIN AND BI-COMPONENT TOXINS
γ-Hemolysin and, to a lesser extent, LukED are hemolytic to rabbit
erythrocytes (Morinaga et al., 2003). PVL is non-hemolytic. To our
knowledge, there is no report of hemolytic activity for LukAB/GH.
While γ-hemolysin and PVL are highly cytotoxic toward human
neutrophils (action at 10 ng/ml), LukAB/GH is only cytotoxic
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toward the same cells at a 100-fold higher concentration (Dumont
et al., 2011). No biological activity had been assigned to LukED
for over 10 years (Gravet et al., 1998) although one variant, named
LukEv–LukDv, was shown to display high leukotoxicity toward
human neutrophils (Morinaga et al., 2003). Recent investigations
of LukED indicate that the LukE and LukD proteins are highly
conserved in S. aureus strains and have a sequence corresponding
to the active LukEvDv and not to the originally described sequence
of LukED (Alonzo et al., 2012). In addition to neutrophils, the bi-
component toxins are active against monocytes and macrophages.
Different species speciﬁcities have been observed for the different
bi-component toxins. Human and rabbit neutrophils are PVL-
sensitive cells, while murine and Java monkey cells are, respec-
tively, largely and fully resistant to PVL-mediated lysis (Lofﬂer
et al., 2010). It is therefore unlikely that the deleterious effects
of PVL observed in the murine model of necrotizing pneumo-
nia (see below) were caused by PVL-mediated neutrophils lysis
(Labandeira-Rey et al., 2007; Zivkovic et al., 2011). In contrast,
LukED is active against human, rabbit, and murine cells (Alonzo
et al., 2012), while γ-hemolysin activity has been mostly studied
against human and murine cells.
The receptors for bi-component toxins are still largely unchar-
acterized. The murine TLR2 ectodomain has been described to
bind LukS-PV, leading to inﬂammation (Zivkovic et al., 2011).
In addition, LukF-PV has been described to bind murine TLR4
(Inden et al., 2009). However, these receptors are unlikely to be the
high afﬁnity receptors triggering very fast lysis at very low doses in
human and rabbit granulocytes and primary monocytes. Indeed,
the murine TLR2/TLR4-dependent effects were observed at con-
centrations a 100-fold greater than the ones triggering 100% lysis
of human neutrophils, monocytes, and macrophages (10μg/ml
vs. 100 ng/ml; Gauduchon et al., 2001; Perret et al., in press). As
previously described for α-hemolysin, lipids have been described
as receptors for LukS and LukF, although it is more likely that
they act as co-receptors (Hakomori, 2003). LukS binds the gan-
glioside GM1, and LukF binds phosphatidylcholine (Noda et al.,
1980). The latter interaction has been conﬁrmed by crystallization
of LukF-PV (Pedelacq et al., 1999), as well as with the homol-
ogous F component of γ-hemolysin, HlgB (Olson et al., 1999).
Binding studies have shown that expression of the receptor for the
S component of PVL and for HglC is limited to PVL-susceptible
cells (Gauduchon et al., 2001). In contrast, the LukF-PV recep-
tor is more broadly expressed (Meyer et al., 2009). Furthermore,
HlgB seems to bind mainly to the corresponding S component on
the host cell membrane (Meyer et al., 2009). These results indi-
cate that the S components of PVL and γ-hemolysin drive the cell
type susceptibilities. Interestingly, HlgC and LukS-PV share the
same uncharacterized receptor on the surface of human granulo-
cytes (Gauduchon et al., 2001). HlgC/HlgB and PVL thus probably
target the same cell types. Furthermore, the two toxins are simi-
larly potent at lysing granulocytes (Konig et al., 1997) and human
macrophages (our unpublished results). Among recombinant bi-
component toxins, PVL and γ-hemolysin are extremely potent,
while LukAB/GH and lukED are active at concentrations 100-fold
higher. The relative secretion of the different toxins in different
conditions remains unknown, but this knowledge would help us
to understand the physiological roles of the different leukotoxins.
β-HEMOLYSIN
The P. aeruginosa hemolytic phospholipase C (PlcHR), which
is an extracellular sphingomyelinase, displays strong speciﬁcity
for endothelial cells (Vasil et al., 2009). This targeting, which
is mediated by a speciﬁc domain of the toxin and a saturable
receptor, makes PlcHR cytotoxic to endothelial cells at concen-
trations 500-fold lower than the dosages toxic to epithelial cells
or macrophages. Similarly, S. aureus β-hemolysin is selectively
cytotoxic tomonocytes and is inactive against lymphocytes, granu-
locytes, andﬁbroblasts (Walev et al., 1996).However, asmonocytes
are equally sensitive to sphingomyelinase C from B. cereus and
from Streptomyces species, it is currently unknown if this result
is due to a speciﬁc targeting of β-toxin to monocytes (possibly
mediated by a speciﬁc receptor) or to a higher sensitivity of these
cells to the toxin.
PHENOL SOLUBLE MODULINS
The current view concerning PSMs is that these peptides do
not have a speciﬁc proteinaceous receptor required for cell lysis.
Indeed, in contrast to other hemolysins, δ-hemolysin is hemolytic
to erythrocytes from numerous species and can lyse organelles, as
well as bacterial protoplasts and spheroplasts (Kreger et al., 1971;
Verdon et al., 2009). Due to its amphipathic α-helix structure,
δ-hemolysin has a natural afﬁnity for lipids. Binding is preferen-
tial in liquid-disordered domains compared to liquid-ordered raft
domains. Lipid composition of eukaryotic and prokaryotic mem-
branes may explain the activity spectrum of PSMs. PSMs show
moderate lytic activity toward granulocytes, and this activity is
observed for only a subset of PSMs and at high concentrations
(10μg/ml for PSMα3 and δ-hemolysin, 50μg/ml for PSM-mec).
In contrast, detection of those peptides by the innate immune
system occurs at concentrations as low at 50 nM (approximately
100 ng/ml; Kretschmer et al., 2010), thus it is unclear if the prime
function of PSMs is to lyse neutrophils or to activate them. PSMs
show activity toward human erythrocytes at lower concentrations
(1μg/ml or 0.1μg/ml if co-incubated with β-hemolysin; Cheung
et al., 2011).
PREVALENCE AND GENE ORGANIZATION
Both colonizing and clinical S. aureus isolates exhibit a large
degree of heterogeneity. The observed heterogeneity can be due
to (i) the presence or absence of a toxin gene, (ii) disruption of
toxin-encoding loci, and (iii) variations in the expression level.
Interestingly, some differences in the membrane-damaging toxin
repertoire or in their level of expression have been linked to
increased virulence or to antibiotic-resistance. The vastmajority of
S. aureus strains contain all the hemolysin genes, hla, hlb, hld, and
hlg. The prevalence of the lukED genes is controversial. Indeed,one
study found lukED genes in 87% of S. aureus strains (Morinaga
et al., 2003; Alonzo et al., 2012) while another group described a
prevalence of about 30% in human clinical and colonizing isolates
(Gravet et al., 1998, 1999, 2001). To the best of our knowledge,
the prevalence of LukAB/GH has not been investigated in a large
number of clinical strains, but these toxins are well-conserved in
all sequenced strains (Shukla et al., 2010; Ventura et al., 2010). In
contrast, the lukS-PV and lukF-PV genes are present in less than
5% of MSSA strains (Vandenesch et al., 2003; Shukla et al., 2010).
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LukS-PV and LukF-PV are encoded within lysogenic phages. A
temperate phageφSLT can convert PVL− strains into PVL+ strains
(Kaneko et al., 1997; Narita et al., 2001). Various lukS/lukF-PV-
transducing phages have been described. This unique genetic
organization makes PVL genes easily transmittable horizontally.
The β-hemolysin-encoding gene is a preferential locus for bac-
teriophage insertion. These insertions disrupt the β-hemolysin
gene. Furthermore, most of the β-hemolysin-targeting bacterio-
phages simultaneously introduce genes encoding components of
the immune evasion cluster (IEC), namely, the staphylokinase,
the staphylococcal enterotoxins A and P, the staphylococcal com-
plement inhibitor (SCIN), and the chemotaxis inhibitory protein
of S. aureus (CHIPS; van Wamel et al., 2006). The vast major-
ity (89%) of human clinical isolates carry two to four compo-
nents of the IEC and thus are β-hemolysin-negative (van Wamel
et al., 2006). In contrast, most S. aureus isolated from bovine
do not have the IEC and express β-hemolysin (Monecke et al.,
2007).
Interestingly, two PSMs are encoded in speciﬁc virulence loci.
Indeed, δ-hemolysin is encoded within RNAIII, a highly struc-
tured 517 nt RNA (Benito et al., 2000) that is part of the agr
regulon (a master virulence regulator system). The PSM-mec-
encoding gene is found within the class A mec gene complex
encoded on type II, III, and VIII SSCmec (Chatterjee et al., 2011),
three methicillin-resistant cassettes integrated into the chromo-
some of certain MRSA strains. Importantly, this last ﬁnding
provided a molecular link between the modulation of virulence
and methicillin-resistance (Queck et al., 2009). However, the link
between PSM-mec and increased virulence is controversial (Chat-
terjee et al., 2011; Kaito et al., 2011) and requires further inves-
tigation (see below). In addition, PSMα and α-hemolysin are
produced at higher level in CA-MRSA strains than in hospital-
acquired (HA)-MRSA strains (Wang et al., 2007; Li et al., 2009),
and PVL is present in most of the community-acquired (CA)-
MRSA lineages that have emerged worldwide (Vandenesch et al.,
2003; Tristan et al., 2007). Although other factors, such as the
arginine catabolic mobile element (ACME), have also been asso-
ciated with CA-MRSA strains (Diep et al., 2006), the change in the
repertoire or the quantity of membrane-damaging factors is also
likely to participate in the high virulence of successful CA-MRSA
clones.
EPIDEMIOLOGY AND ROLE IN S. AUREUS -DISEASES
The roles of S. aureus membrane-damaging factors have been
investigated both by epidemiological studies in humans and by
experimental infections with various mutants in diverse animal
models.
EPIDEMIOLOGY
Robust epidemiological studies can only be performed on vir-
ulence factors that have a low prevalence and without associa-
tion with a speciﬁc lineage. This requirement is true for PVL in
CA-MSSA strains and for β-hemolysin regardless of methicillin-
resistance status. To the best of our knowledge (and based onVan-
denesch and Lina, unpublished data), the presence of β-hemolysin
has not been associated with any speciﬁc human diseases or with
severity criteria. The lowprevalence of this factor inhuman isolates
suggests that this factor is less important in human infection than
the presence of the IEC components. The high prevalence of α-,
γ-, and δ-hemolysin and α and β-PSMs prevents epidemiological
studies from assessing their roles in speciﬁc human diseases or
association with severity criteria. Nevertheless, their high preva-
lence suggests that these factors play a key role in colonization
and/or diseases. Although LukAB/GH is highly prevalent (Ventura
et al., 2010), it has been reported to be absent in certain colonizing
and clinical isolates (see Figure S5 inDumont et al., 2011). It is thus
unclear if epidemiological studies on LukAB/GH would be infor-
mative. An increased prevalence of lukED genes has been observed
in clinical strains isolated from cases of impetigo (Gravet et al.,
2001) and from patients presenting antibiotic-associated diarrhea
(Gravet et al., 1999). Due to the limited and controversial knowl-
edge regarding LukED prevalence, the biological signiﬁcance of
these interesting associations remains unclear. PSM-mec has been
only recently identiﬁed, and epidemiological studies have yet to be
performed (Chatterjee et al., 2011).
There is compelling evidence that PVL is associated with a
severe form of CA-MSSA pneumonia occurring in otherwise
healthy children and young adults (Lina et al., 1999; Gillet et al.,
2002). PVL is also associated with increased severity, treatment
duration, and extra osseous complications in bone and joint infec-
tions, especially in children (Bocchini et al., 2006; Dohin et al.,
2007). The role of PVL in SSTI is more debated (Bae et al.,
2009), but several studies demonstrate a signiﬁcant association
between PVL and CA-SSTI (Shallcross et al., 2010; Del Giudice
et al., 2011). This association is particularly strong in primary
skin lesions, such as furunculosis (Gravet et al., 2001; Del Giu-
dice et al., 2009, 2011). In contrast, no clear role of PVL has
been identiﬁed in CA-MRSA infections. However, epidemiolog-
ical studies regarding PVL and CA-MRSA-diseases have proven
difﬁcult, due to the high prevalence of PVL in CA-MRSA strains
in North America and to the clonality of these CA-MRSA strains
(Bae et al., 2009). In a similar vein, PVL is statistically associ-
ated with major MRSA abscesses but does not seem to affect SSTI
patients’ outcome (Bae et al., 2009). Furthermore, PVL is not
associated with hospital-acquired/ventilation associated MRSA
pneumonia (Peyrani et al., 2011). Of note, in these two studies,
PVL+ strains are statistically associatedwith younger patients than
PVL− strains. This observation suggests that PVL is a virulence
factor in immunocompetent and not immunosenescent patients.
Alternatively, an increase in the likelihood of being immunized
against PVL with age might explain why PVL+ strains are more
often associated with infections in children and young adults than
with infections in older patients. Indeed, serum antibody titers
speciﬁc for S. aureus toxins increase with age (Hermos et al.,
2010; Verkaik et al., 2010). However, Hermos and collaborators
did not observe any protection against PVL+ SSTI in patients
with high anti-PVL antibody levels. In contrast, Rasigade et al.
(2011) found that patients presenting a history of PVL-associated
infections were protected from death in PVL-associated necrotiz-
ing pneumonia. Overall, these studies suggest that PVL-directed
immunity does not protect the host from being re-infected and
from developing severe infections, such as necrotizing pneumo-
nia, but it may favor a positive outcome (survival) in severe
diseases.
Frontiers in Cellular and Infection Microbiology www.frontiersin.org February 2012 | Volume 2 | Article 12 | 5
Vandenesch et al. Staphylococcus aureus membrane-damaging factors
ANIMAL MODELS
Numerous animal models have been used to study the impact
of membrane-damaging factors on S. aureus infection (Table 2).
Strikingly, while iron is known to be a limiting nutrient during
infections, it is still unknown if hemolysis occurs in vivo andwhich
hemolysin is important in acquiring iron. α-Hemolysin is the key
virulence factor emerging from in vivo studies. α-Hemolysin is a
critical virulence factor in brain abscesses (Kielian et al., 2001),
SSTI (Kobayashi et al., 2011), and pneumonia (Bubeck Warden-
burg et al., 2007). The role of α-hemolysin in bacteremia is less
obvious (Bayer et al., 1997), which is consistent with a major role
of α-hemolysin at epithelial surfaces (see below). In contrast, the
role of the other hemolysins is still poorly deﬁned. β-hemolysin
promotes inﬂammation and lung injury in a mouse model of
pneumonia (Hayashida et al., 2009), and γ-hemolysin promotes
bacterial growth and triggers inﬂammation in a rabbit model of
endophthalmitis (Supersac et al., 1998). LukAB/GH is important
for survival in human blood and increases the bacterial burden
in the kidney during a murine model of bloodstream infection
(Dumont et al., 2011). Similarly, deletion of the lukE and lukD
genes attenuates S. aureus virulence and decreases lethality in a
murine model of bloodstream infection (Alonzo et al., 2012).
As described above and in contrast to several other S. aureus
virulence factors, PVL is poorly cytotoxic to murine cells (Lofﬂer
Table 2 | Membrane-damaging factors and their role in various diseases in various animal models.
Disease Animal Inoculum
(strain type)
Virulence
factor
Phenotype of the animal infected with the
mutant strain as compared to theWT strain
Reference
Skin infection Rabbit 5× 108 MRSA (USA 300 Lac) hla Decreased cfu, decreased abscess size Kobayashi et al. (2011)
PSMα Decreased cfu, decreased abscess size
PVL Decrease cfu, increased abscess size at
resolution stage
Skin infection Rabbit 108 MRSA (USA 300 Lac) PVL Decreased lesion size, decreased necrotic
lesion size
Lipinska et al. (2011)
Osteomyelitis Rabbit 4× 108 MRSA (USA 300 Lac) PVL No bone deformation at day 7, decreased cfu at
day 28
Cremieux et al. (2009)
Necrotizing soft
tissue infection
Mice 109 cfu PVL No difference in cfu, No difference in skin lesion
size, decreased muscle lesions in BalB/c mice
not in C57BL6J mice
Tseng et al. (2009)
Necrotizing
pneumonia
Rabbit 1010 cfu (USA 300 SF8300) PVL Decreased mortality, decreased inﬂammation Diep et al. (2010)
Necrotizing
pneumonia
Mice Puriﬁed PVL (3μg
LukS+ 3μg LukF)
PVL Death, neutrophil recruitment Labandeira-Rey et al.
(2007)
Necrotizing
pneumonia
Mice 2.107 cfu (LUG855) PVL Decreased mortality, decreased inﬂammation
Bacteremia Rabbit PVL Decreased cfu in the kidney at 24–48 h PI not at
72 h PI
Diep et al. (2008)
Bacteremia Mice 1.106 cfu (USA 300 Lac) LukAB/GH Decreased cfu in the kidney at day 4 PI Dumont et al. (2011)
Bacteremia Mice 108 cfu (Mw2) PSMα Decreased mortality, less TNFα Wang et al. (2007)
PSMβ No role
hld Decreased mortality, less TNFα
Skin infection Mice 107 cfu (Mw2) PSMα Decreased lesion size Wang et al. (2007)
PSMβ Increased lesion size
hld No role
Bacteremia Mice 108 cfu (MSA890)1 PSM-mec Decreased mortality Queck et al. (2009)
Skin infection Mice 107 cfu (MSA890) PSM-mec No dermonecrosis, no weight loss
Pneumonia Mice 2–4× 108 cfu (Lac) hla Decreased mortality Bubeck Wardenburg
et al. (2007)
Pneumonia Mice 2–4× 108 cfu (MW2 or Lac) PVL No effect Bubeck Wardenburg
et al. (2007)
Pneumonia Mice 1.2× 108 cfu (8325.4) hlb Decreased inﬂammation, decreased lung injury Hayashida et al. (2009)
Pneumonia Mice 15μg hlb hlb Increased inﬂammation, increased lung injury Hayashida et al. (2009)
Endophthalmitis Rabbit 102 cfu hlg Decreased cfu at day 4 PI, decreased
inﬂammation at day 3 PI
Supersac et al. (1998)
Brain abscess Mice 105 cfu (RN6390) hla Decreased cfu, decreased inﬂammation Kielian et al. (2001)
Due to controversial results, we present a larger coverage on studies testing the role of PVL. 1A strain with low production of core genome-encoded PSM.
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et al., 2010). The low activity of PVL against murine cells has cast
doubt on the results showing an effect of PVL in murine models
of pneumonia and SSTI (Bubeck Wardenburg et al., 2007, 2008;
Labandeira-Rey et al., 2007; Brown et al., 2009; Tseng et al., 2009;
Otto, 2010; Vandenesch et al., 2010). These phenotypes might be
linked with the high inocula used in these studies, which might
bypass the low sensitivity of murine cells. In some cases, rabbit
infection models have also led to controversial results concern-
ing the role of PVL. Indeed, depending on the studies, PVL has
been shown to play either a major role in skin inﬂammation and
lesions (Lipinska et al., 2011) or only a minor role in promoting
bacterial replication and survival early on and even accelerat-
ing infection resolution and healing at later stages (Kobayashi
et al., 2011). Similarly, PVL plays a minor role in S. aureus rab-
bit bacteremia (Diep et al., 2008), while it contributes to per-
sistence and extra osseous involvement in rabbit osteomyelitis
(Cremieux et al., 2009). Finally, experimental infections in rabbit
have proven a goodmodel for studying necrotizing pneumonia. In
this model, PVL triggers massive lung inﬂammation, neutrophil
recruitment, and promotes lung damage and death in infected
animals. Importantly, this activity is dependent on the presence
of vinblastine-susceptible cells, which include neutrophils and all
other circulating leukocytes, supporting a role for PVL targeting
of neutrophils in this immune pathology (Diep et al., 2010).
Phenol soluble modulins α have also been involved in pro-
moting death in bacteremia models and increasing the extent of
the skin lesions in experimental SSTI (Wang et al., 2007; Queck
et al., 2009). Importantly, the role of PSM-mec has been studied
in a strain expressing low levels of core genome-encoded PSMs,
suggesting that the presence of PSM-mec might not provide a
novel virulence attribute in the presence of highly expressed core
genome-encoded PSMα (Queck et al., 2009; Chatterjee et al.,
2011). Conversely, in another study, PSM-mec was shown to
reduce the severity of S. aureus sepsis in a mouse systemic infec-
tionmodel, owing to its regulatory effect on core genome-encoded
virulence factors (Kaito et al., 2011).
INFLAMMATION AND DETECTION BY THE INNATE IMMUNE
SYSTEM
While it is clear that certain membrane-damaging toxins have
evolved to speciﬁcally target innate immune cells, the converse
is also true. Indeed, the innate immune system has evolved sev-
eral pathways to sense membrane damage (Figure 1; Henry and
Lemichez, 2012).
PERTURBATION OF Ca2+ HOMEOSTASIS: NF-κB AND PLA2 ACTIVATION
There is a large difference inCa2+concentrationbetween the extra-
cellular environment ([Ca2+]> 1mM) and the host cytoplasm
([Ca2+]i< 100 nM). Pore formation leads to a rapid rise in intra-
cellular calcium concentration associated with either direct inﬂux
through the pore or with a release from intracellular compart-
ments, such as the endoplasmic reticulum. This calcium increase
has been well exempliﬁed in rabbit PMNs treated with sub-
lytic α-hemolysin doses (Suttorp and Habben, 1988). Depending
on their frequency, oscillations in [Ca2+]i trigger activation of
various transcription factors (Dolmetsch et al., 1998) including
NF-κB. Calmodulin, a calcium binding protein, is the primary
intracytoplasmic calcium sensor. Upon calciumbinding-mediated
conformation changes, calmodulin binds to and activates several
proteins, including calcineurin, a protein phosphatase. Activated
calcineurin activates the IKKb complex (I kappa B Kinase). Acti-
vated IKKb phosphorylates IκB (Frantz et al., 1994), a protein
sequestering NF-κB into the cytosol, leading to IκB degrada-
tion, and the release of NF-κB (Henkel et al., 1993). One of the
main NF-κB-inducible genes is IL-8 (CXCL8), a potent neutrophil
chemoattractant. IL-8 is produced by PMNs treated with sublytic
doses of α-hemolysin or PVL (Konig et al., 1994). This response is
not limited to professional immune cells, as α-hemolysin-treated
alveolar epithelial cells also release IL-8 (Rose et al., 2002).
In addition to regulatingNF-κB activation, increases in [Ca2+]i
activate the cytoplasmic phospholipase A2 (PLA2). Cytoplas-
mic PLA2 hydrolyzes arachidonic acid-containing phospholipids,
leading to the generation of arachidonic acid-derived lipid medi-
ators, such as PGE2 and LTB4. An increase in [Ca2+]i leads
to relocation of cPLA2 to the phospholipid-containing plasma
membrane and triggers its phosphorylation by a calmodulin-
dependent kinase, leading to greater catalytic activity (reviewed
in Hirabayashi et al., 2004). Treating human neutrophils or alveo-
lar epithelial cells with sublytic doses of α-hemolysin triggers LTB4
generation (Suttorp et al., 1987; Rose et al., 2002). In PMNs, LTB4
generation is abolished by chelation of extracellular calcium (Sut-
torp et al., 1987). Similarly, PVL triggers LTB4 secretion, although
the inﬂuence of extracellular calcium has not been investigated
(Hensler et al., 1994).
PERTURBATION OF K+ HOMEOSTASIS: MAPK AND INFLAMMASOME
ACTIVATION
While calcium concentration is higher in the extracellular environ-
ment than in the cytosol, the potassium (K+) gradient is inversely
orientated. The intracellular potassium concentration ([K+]i) is
143mM,while the extracellular potassium concentration does not
exceed 5mM.
α-Hemolysin triggers K+ efﬂux upon insertion in the mem-
brane of human keratinocytes. While the pore formed by α-
hemolysin at low concentrations is speciﬁc formonovalent cations
(Walev et al., 1993), at higher doses, Ca2+ can also ﬂow through
the pore. Cells are capable of detecting a drop in [K+]i,which leads
to the activation of several immune pathways. Indeed,MAPK p38
phosphorylation is observed followingα-hemolysin stimulationof
a humankeratinocyte cell line, and this phosphorylation is blocked
by the presence of high extracellular [K+] (Kloft et al., 2009).
Conversely, adding a K+ ionophore, nigericin, to cells can recapit-
ulate p38 activation in the absence of bacterial toxin, indicating
that K+ efﬂux is sufﬁcient to activate p38 MAPK. In addition,
osmotic stress triggered by sublethal α-hemolysin doses activates
p38 MAPK in epithelial cells (Ratner et al., 2006). p38 MAPK
activation results in NF-κB activation and IL-8 production.
In addition to activating the MAPK pathway, decreased [K+]i
is required to trigger another innate immune signaling path-
way, namely, the inﬂammasome. The inﬂammasome is a cytosolic
signaling platform assembled after sensing PAMPs or danger sig-
nals that leads to caspase-1 activation (reviewed in Brodsky and
Monack, 2009). Caspase-1 is an inﬂammatory caspase that cleaves
proIL-1β and proIL-18, leading to secretion of the corresponding
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FIGURE 1 | Interplay between membrane-damaging (poly)peptides and
the innate immune system. (1) In physiological conditions, differences in
[Ca2+] and [K+] are actively maintained between the extracellular space and
the cytosol. (2) Insertion of a PFT or membrane damage leads to a direct or
indirect rise in [Ca2+]i. (3) Similarly, engagement of FPR2 by PSMα triggers an
increase in [Ca2+]i. (4) [Ca2+]i controls NF-κB and (5) cPLA2 activation. (6) TLR2
and 4 might also trigger NF-κB translocation in the nucleus by sensing
LukS-PV and LukF-PV. (7) Insertion of a PFT or membrane damage leads to a
rapid fall in [K+]i, leading to (8) MAP kinase and (9) NLRP3 inﬂammasome
activation. (10) Ceramide generated by β-hemolysin might also directly
activate the NLRP3 inﬂammasome. (11) In addition, ceramide has been
reported to inhibit IL-8 secretion.
mature cytokines. Furthermore, caspase-1 triggers a form of pro-
grammed necrosis known as pyroptosis (Cookson and Brennan,
2001). Inﬂammasome-dependent IL-1β release is critical for neu-
trophil recruitment and bacterial clearance in a mouse model of S.
aureus cutaneous infection (Miller et al., 2007). Numerous PFTs,
including α-hemolysin and β-hemolysin on human monocytes
(Bhakdi et al., 1989; Walev et al., 1996; Craven et al., 2009), PVL
on human macrophages (Perret et al., in press), and α- and γ-
hemolysins on murine microglial cells (Hanamsagar et al., 2011)
activate IL-1β release. PFT activates the inﬂammasome via the
inﬂammasome receptor NLRP3, which is also known as cryopy-
rin, and the adaptor protein ASC. It is still unclear how pore
formation is translated into a NLRP3 signal (reviewed in Mar-
tinon, 2010). Intracellular K+ depletion seems to be a key event
controlling this activation. Indeed, α-hemolysin-mediated activa-
tion of the NLRP3 inﬂammasome can be inhibited in presence
of high extracellular K+ concentrations (Fernandes-alnmeri et al.,
2007). Furthermore, as described before for MAP kinase activa-
tion, treatment of macrophages with nigericin, a bacterial K+
ionophore, triggers NLRP3-mediated inﬂammasome activation
(Mariathasan et al., 2006). Other possible mechanisms include
toxin-mediated destabilization of lysosomes with the concomi-
tant release of cathepsins into the host cytosol (Hornung et al.,
2008) or sensing of ceramide by NLRP3, which might be relevant
following β-hemolysin intoxication (Vandanmagsar et al., 2011).
FPR2 AND THE DETECTION OF PSMs
While the two immune responses described above are linked to
membrane-damaging activity, PSMs can trigger intracellular Ca2+
ﬂux, chemotaxis, and IL-8 secretion independently of membrane-
damaging. Indeed, a host receptor, the formyl peptide receptor
2 (FPR2/ALX), can detect PSMs at nanomolar concentrations
(Kretschmer et al., 2010). Despite its name, FPR2 detects non-
formylated PSMs as efﬁciently as formylated PSMs. To date, it
is not yet understood whether the innate immune system has
evolved FPR2-mediated sensing of PSMs to detect Staphylococcus
species or whether highly virulent S. aureus strains have evolved
PSMs targeting of FPR2 to trigger a massive recruitment of neu-
trophils associated with massive leukotoxic activity (Kretschmer
et al., 2010; Rautenberg et al., 2011).
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TLR2, TLR4, AND PVL DETECTION
In necrotizing pneumonia, PVL is associated with massive inﬂam-
mation leading to necrotic lesions in human lung necropsies
(Gillet et al., 2002) and in animal models (Labandeira-Rey et al.,
2007; Diep et al., 2010). While consensus view is that this inﬂam-
mation is due to the inﬂammatory necrotic death of neutrophils
and the release of associated DAMPs (Krysko et al., 2011), two
studies have demonstrated the binding of LukS-PV and LukF-PV
by TLR2 (Zivkovic et al., 2011) and TLR4 (Inden et al., 2009),
respectively. While contamination with LPS, lipopeptides, or cell-
wall component is always difﬁcult to exclude, these studies suggest
that PFT might be a novel PAMP recognized by TLRs.
NON-LYTIC FUNCTIONS OF THE MEMBRANE-DAMAGING
POLYPEPTIDES
To date, most of these factors have been characterized for their
hemolytic properties and their ability to lyse host cells. However,
membrane-damaging activity might only be the tip of the iceberg,
hiding more physiological functions. In this section, we review
alternative functions recently uncovered for these virulent factors
(Figure 2).
RECEPTOR ACTIVATION
As described above, the host receptors targeted by these differ-
ent toxins remain unknown in most cases. However, ADAM10
has been recently identiﬁed as a α-hemolysin receptor (Wilke and
Bubeck Wardenburg, 2010). Importantly, α-hemolysin binding
to ADAM10 increases its metalloprotease activity and targets it
to caveolae. Localized ADAM10 activation results in E-cadherin
cleavage and disruption of intercellular tight junctions leading to
epithelial barrier disruption (Tunggal et al., 2005). Surprisingly,
the ability of α-hemolysin to form a pore is critical for ADAM10
activation, but it can be achieved at sublytic concentrations of α-
hemolysin, suggesting that ion ﬂux through α-hemolysin pores
might be important for activating ADAM10 (Inoshima et al.,
2011).
ESCAPE FROM THE PHAGOSOME
Staphylococcus aureus is classically considered to be an extracellu-
lar pathogen. However, clear evidence indicates that in the host,
S. aureus can survive within an intracellular compartment (Bayles
et al., 1998; Gresham et al., 2000; Giese et al., 2011), which may
be relevant during persistent infections (Clement et al., 2005;
Plouin-Gaudon et al., 2006). Importantly, S. aureus is found intra-
cellularly in non-professional phagocytes, either in a membrane-
bound compartment or in the host cytosol. Escape into the host
cytosol involves a synergistic activity of δ-toxin or PSMβ and β-
toxin (Giese et al., 2011). Furthermore, α-hemolysin is involved
in phagosomal membrane lysis in CFTR-deﬁcient cells, possibly
explaining the persistence of S. aureus in cystic ﬁbrosis patients
(Jarry and Cheung, 2006; Jarry et al., 2008; Giese et al., 2009).
ADHESION
Panton Valentine leukocidin positive strains display stronger
attachment to the cellular basementmembrane than PVL− strains
(De Bentzmann et al., 2004). Surprisingly, this function was
ascribed to the ability of LukS-PV signal peptides (SPs) to inter-
act with heparan sulfates in the extracellular matrix (Tristan et al.,
2009). While the interaction between LukS-PV SPs and heparan
sulfate is of relatively low afﬁnity, the large number of LukS-PV
SPs associated with the cell-wall together with the large number
of heparan sulfate ligands present could compensate for the low
afﬁnity by a high-avidity binding. The relevance of this binding to
PVL-mediated pathogenesis remains to be addressed.
INTERFERENCE WITH INFLAMMATORY PATHWAYS
While β-hemolysin has mainly been characterized for its
hemolytic activity, it differs from the other membrane-damaging
(poly)peptides described above in its unique neutral sphin-
gomyelinase activity. Sphingomyelin hydrolysis in eukaryotic
membranes leads to the release of a very potent second messen-
ger, ceramide, as well as to the release of the chemotactic molecule
sphingosine-1-phosphate. β-hemolysin inhibits IL-8 production
by endothelial cells in a manner similar to that of exogenous
ceramide. This inhibition of IL-8 production correlates with a
decrease in neutrophil transmigration across the endothelial bar-
rier (Tajima et al., 2009), suggesting that β-hemolysin could coop-
erate with other S. aureus chemotaxis inhibitors, such as CHIPS
(Foster, 2005).
BIOFILM REGULATION
Phenol soluble modulins-β in S. epidermidis have been convinc-
ingly demonstrated to participate in the maturation of the bioﬁlm
structure, speciﬁcally in formation of the intra-bioﬁlm channels,
and in mediating bacterial detachment from the bioﬁlm at high
concentrations. In a mouse model of catheter-related infection,
PSMβ were essential in disseminating from the catheter bioﬁlm to
systemic organs (Wang et al., 2011). PSMβ in S. aureus share the
α-helical amphipathic structure of S. epidermidis PSMβ. PSMβ are
thus likely to perform the same bioﬁlm regulatory functions in S.
aureus. Similarly, β-toxin, in addition to its neutral sphingomyeli-
nase activity, has a structure reminiscent of the DNAse I protein.
In presence of exogenous DNA, β-toxin displays the unique abil-
ity to oligomerize covalently and precipitate DNA. β-hemolysin
mutants have a reduced adherence and are defective in bioﬁlm
formation, suggesting that this oligomerization activity in pres-
ence of DNA could participate in bioﬁlm formation, possibly by
forming a nucleoprotein network facilitating bioﬁlm structuration
(Huseby et al., 2010).
GLOBAL DYSREGULATION
As mentioned above, PSM-mec was the ﬁrst virulence factor
identiﬁed in the SCCmec element, which carries the methicillin-
resistance genes (Queck et al., 2009). Beside its direct cytolytic
and pro-inﬂammatory functions, the PSM-mec peptide and its
messenger RNA were found to suppress colony spreading and
to enhance bioﬁlm formation, while the PSM-mec mRNA also
repressed the synthesis of the core genome-encoded PSMα (Kaito
et al., 2011). However, as this latter effect seems to be observed
only upon ectopic expression of PSM-mec from a plasmid, its
relevance is questionable (Chatterjee et al., 2011). The mecha-
nism for this dysregulation is still unknown but is reminiscent
of the regulatory effect observed with the toxic-shock syndrome
toxin-1 (TSST-1), which represses the transcription of many exo-
protein genes (Vojtov et al., 2002). Similarly, PVL promotes the
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FIGURE 2 | Non-lytic functions of hemolysins, bi-component toxins, and
PSMs. (1) E-cadherin is important for maintaining tight junctions and epithelial
barrier function. α-Hemolysin binds ADAM10 and relocalizes it to
E-cadherin-containing microdomains. ADAM10 cleaves E-cadherin, leading to
loss in epithelial barrier function. (2) Exposure of the underlying
glycosaminoglycans-rich extracellular matrix to LukS-PV signal peptide favors
S. aureus adhesion. (3) PSM-mec RNA controls the transcription of virulence
factors, including PSMα. (4) β-Hemolysin binds DNA, forming nucleoproteins
nucleating S. aureus bioﬁlm. PSMβ acts as surfactant, promoting the
formation of intra-bioﬁlm tunnels and bacterial dissemination from bioﬁlms.
PSM-mec enhances bioﬁlm formation (5) In addition, PSMs have antibacterial
activity, which may be relevant in lysing competing colonizing bacteria. (6)
Finally, PSMs in synergy with β-hemolysin participate in phagosome lysis and
escape into the host cytosol.
expression of staphylococcal protein A at the transcriptional level,
which is an effect that could synergize with the pro-inﬂammatory
activity of PVL and contribute to the pathogenesis of necrotizing
pneumonia (Labandeira-Rey et al., 2007). Unexpectedly, this dys-
regulatory effect is restricted to the 8325-4 lineage (Vandenesch,
unpublished), limiting the clinical relevance of this observation.
ANTIBACTERIAL ACTIVITY
δ-Toxin lyses bacterial protoplasts and spheroblasts. Similarly, the
PSMβ-like peptides SLUSH-A, B, and C have been isolated from
S. lugdunensis (Donvito et al., 1997; Rautenberg et al., 2011) and
are described as having discrete anti-staphylococcal activity. PSMα
and, to a lesser extent, PSMβ demonstrate bacteriostatic activity
against Legionella at concentration 10-fold lower than the concen-
trations required to lyse 10% of a human erythrocytes suspension
(Marchand et al., 2011). Finally, the antimicrobial activity against
S. pyogenes and M. luteus present in the supernatant of CA-MRSA
is abolished in mutants with the PSMα and β genes deleted. Fur-
thermore, PSMα1 and PSMα2, when deleted from their two Nter
aminoacids, display a high bacteriolytic activity against S. pyo-
genes (Joo et al., 2011). The processing mechanisms responsible
for generating these potent antimicrobial peptides from inactive
PSMs is still unknown but might be a key regulatory step, allowing
a switch of target from host cells to competing bacteria. Overall,
these studies suggest that PSMs, possibly in conjunction with host
antimicrobial peptides (Cogen et al., 2010), help S. aureus to com-
pete with other bacteria colonizing the same ecological niche. As
CA-MRSA are robust PSM producers, this colonization advantage
could explain its rapid spreadworldwide (Joo et al., 2011). The rel-
evance of this antibacterial activity in colonization and infection
remains to be investigated.
CONCLUSION AND PERSPECTIVES
While the hemolytic and leukotoxic activities of S. aureus have
been known for more than a century, the molecular nature of
the factors involved in this bacterium’s pathogenesis are still
being uncovered. The identiﬁcation of α-hemolysin receptors has
highlighted the key role of this virulence factors in several S.
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aureus-diseases involving epithelial barrier disruption. Similarly,
identifying the host receptors for the other membrane-damaging
toxins is likely to yield novel insights into the physiological and
speciﬁc functions of the different factors and to help us progress
beyond the apparent redundancy of all these factors. Further-
more, the putative role of hemolysins, leukotoxins, and PSMs in
S. aureus colonization is still uncharacterized but should provide
important knowledge on the balance between commensalism and
infection.
While hemolysis and leukotoxicity have stood as the major role
of these virulence factors for decades, it is increasingly clear that the
membrane-damaging toxins and peptides might have other func-
tions besides killing host cells. These other functions are nowwell-
established for α-hemolysin, but secondary functions for other S.
aureus secreted virulence factors are also emerging as a paradigm,
as illustrated in this review. Inmost instances, the relevanceof these
functions as compared to their membrane-damaging functions
remains to be established.
Another key challenge in the ﬁeld will be to understand the
temporal and spatial regulation of these different virulence fac-
tors. Indeed, different in vitro growth conditions are used to
obtain secretion of the different membrane-damaging factors,
suggesting that these virulence factors are secreted in response
to different environmental cues or at different stages during col-
onization or infection. Furthermore, differential diffusion of the
toxins and peptides within tissuesmight lead to different functions
(e.g., sublytic vs. lytic concentrations) at various distances from the
bacteria (e.g., local vs. systemic effects).
As noted in this review, these virulence factors interact inti-
matelywith the immune systemby both actively targeting immune
cells and being actively detected by the innate immune system. To
date,most of the researchhas focused onneutrophils,but endothe-
lial cells and epithelial cells are also emerging as central players
in triggering and regulating the immune responses (Dolowschiak
et al., 2010; Teijaro et al., 2011). Furthermore, dendritic cells
and inﬂammatory monocytes are key in regulating inﬂammatory
responses at the epithelial barrier. Study of the interaction between
these virulence factors and host cells in more physiological models
is thus likely to provide us novel important ﬁndings.
The spread of highly virulent CA-MRSA is a major concern.
Increased prevalence of leukotoxins, such as PVL, and increased
expression of membrane-damaging factors, such as α-hemolysin
and PSMs, have been observed in these strains. A better under-
standing of the synergistic actions of these virulence factors in
relevant animal models is required to understand their potential
roles in the worldwide spread of these bacteria.
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